Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore Medical Dialogues Bureau31 July 2019 9:00 AM ISTPiramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
NeuroVive's NeuroSTAT Project Receives USFDA Fast Track Designation Medical Dialogues Bureau30 July 2019 2:20 PM ISTNeuroVive Pharmaceutical AB announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain...
Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors Farhat Nasim30 July 2019 2:08 PM ISTNew Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
Cipla Gulf, Alvotech partner to commercialise AVT02 Biosimilar of AbbVie's Blockbuster drug Humira Medical Dialogues Bureau30 July 2019 1:15 PM ISTMumbai: Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical...
Strides Pharma inks JV pact with China's Sihuan Pharma Medical Dialogues Bureau30 July 2019 12:47 PM ISTChina: Strides Pharma Science said on Monday it has entered into a joint venture with China's Sihuan Pharmaceutical Holdings Group with a view to fast...
Cipla asks Government to increase fund allocation for healthcare sector Medical Dialogues Bureau29 July 2019 6:09 PM ISTAddressing shareholders in the company's Annual Report for 2018-19, Cipla Chairman Y K Hamied said basic healthcare in the country will always require...
Granules India completes USFDA inspection for Bonthapally facility with one observation Farhat Nasim29 July 2019 10:00 AM ISTGranules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
Cipla arm, Alvotech enter partnership for commercialization of adalimumab biosimilar AVT02 Medical Dialogues Bureau29 July 2019 9:45 AM ISTUnder the partnership, Alvotech will be responsible for the development and supply of AVT02, an adalimumab biosimilar, while Cipla Gulf will be...
Pfizer, Mylan in talks to merge off-patent drugs business Medical Dialogues Bureau29 July 2019 9:30 AM ISTMylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the...
Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit Medical Dialogues Bureau29 July 2019 9:17 AM ISTNovartis is revamping Sandoz, a process Narasimhan has previously said will take roughly the next year and a half. He has already sold a generic U.S....
Alkem Labs Founder Samprada Singh passes away at the age of 92 years Medical Dialogues Bureau29 July 2019 9:00 AM ISTPatna: Mumbai-based drugmaker, Alkem Laboratories Founder and Chairman Emeritus, Samprada Singh expired on Saturday at the age of 92 years after a...
Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter Farhat Nasim29 July 2019 9:00 AM IST"We have had a steady performance during the quarter. Pharmaceutical segment revenues have been higher by 12 per cent YoY led by growth in CMO,...
